Webinar: Implementation at Univ of Maryland Biorepository

About UMM Biorepository The University of Maryland School of Medicine established a biorepository intending to provide the resources and support for large-scale studies. They aim to empower basic and clinical researchers to make discoveries in genomics and ‘omics’ sciences and translate these discoveries to more effective diagnostics and therapeutics. Currently, the UMM Biorepository has data of 28000+ […]

Biobanking Conversations #2 with Gavin Higgins (Victorian Cancer Biobank)

Your Name:  My name is Gavin Higgins.  Explain your role in brief:  I am the Project Manager for the Victorian Cancer Biobank. I  manage client inquiries, project applications, implementation, and coordination of projects across the consortium. This may include dispatch of banked specimens and associated data to researchers, a bespoke collection of biospecimens, and clinical […]

OpenSpecimen and COVID19

“According to Darwin’s Origin of Species, it is not the most intellectual of the species that survives; it is not the strongest that survives; but the species that survives is the one that is able best to adapt and adjust to the changing environment in which it finds itself.” – Leon C. Megginson The pandemic has […]

How OpenSpecimen Biobanking LIMS helped the Univ of California Davis achieve CAP accreditation?

Research in precision medicine requires a continuous supply of high-quality biospecimens. But as the saying goes- “Garbage in garbage out”, meaningful conclusions from the studies can only be drawn when the researchers are assured that the materials used in their research were of good quality. A survey(1) conducted by the National Cancer Institute (NCI) funded cancer […]

university of california cap accreditation using biobanking lims

Is OpenSpecimen CFR Part-11 Compliant?

The short answer is Yes. However, it is important to note that the software itself cannot be compliant. Rather, it is the implementation and use of software that determines compliance. It is achieved only when a study has the procedures, policies, documentation, training, and validation that meets Part-11 requirements. An FDA auditor will review all […]

Managing Longitudinal Collections In OpenSpecimen

Managing biospecimen data for longitudinal studies or clinical trials can be challenging. Clinical studies often go on for months or years, and involves complex workflows like kit preparations, tracking upcoming visits, multi-site collections, shipments, and so forth. To manage these types of collections, OpenSpecimen offers a customizable platform to plan, manage and track biospecimens in a […]

Improving interoperability and quality of data using OpenSpecimen at VCB (Melbourne)

Following is a poster presented by the Victorian Cancer Biobank team on using OpenSpecimen for ‘Improving interoperability and quality of data’ at the ABNA 2019 conference. VCB has collected more than 600,000 biospecimens from a broad range of tumours, and approximately 423,000 biospecimens are currently in our inventory. OpenSpecimen was implemented as the biobank information […]